课题基金 / 基金详情

ROPINIROLE AS ADJUNCT TO L-DOPA IN THE TREATMENT OF PARKINSON'S DISEASE

ROPINIROLE AS ADJUNCT TO L-DOPA IN THE TREATMENT OF PARKINSON'S DISEASE
罗匹尼罗辅助左旋多巴治疗帕金森病
批准号：
3786547
负责人：
STEPHEN T GANCHER
金额：
$0.0万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3786547
关键词：
Parkinson's disease antiparkinson drugs clinical trials combination chemotherapy dihydroxyphenylalanine dosage human subject human therapy evaluation indoles nervous system disorder chemotherapy

项目摘要

项目成果

STEPHEN T GANCHER的其他基金

相关文献

中文摘要
翻译
这项为期10周的双盲安慰剂对照4组平行研究是 旨在评价罗匹尼罗的最低有效剂量， 辅助左旋多巴治疗帕金森病患者 用左旋多巴控制
英文摘要
This 10-week double-blind placebo controlled 4-group parallel study is designed to evaluate the minimally effective dose of Ropinirole as adjunct to L-DOPA treatment in Parkinsonian patients not optimally controlled on L-DOPA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SUBLINGUAL APOMORPHINE IN PARKINSON'S DISEASE--TOLERABILITY AND EFFICACY
SUBLINGUAL APOMORPHINE IN PARKINSON'S DISEASE--TOLERABILITY AND EFFICACY
SUBLINGUAL APOMORPHINE IN PARKINSON'S DISEASE--TOLERABILITY AND EFFICACY
ALTERATIONS IN DOPAMINERGIC RESPONSE IN PARKINSONISM